Little House Capital’s Labcorp LH Stock Holding History

Little House Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-134	Closed	-$17K	–	200
2019 Q1	$17K	Buy	+134	New	+$16.5K	0.01%	220

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Little House Capital's LH Position: Q2 2019 in Review

Little House Capital sold out of Labcorp (LH) in Q2 2019, closing a stake of 134 shares — an estimated $17K sold.

Little House Capital first reported a position in LH in Q1 2019 and held it in 1 quarter. The position peaked at $17K in Q1 2019. 741 funds tracked by Wall St. Rank hold LH as of Q2 2019.

Little House Capital reported no remaining Labcorp position as of Q2 2019 after selling out during the quarter.
Little House Capital sold 134 Labcorp shares in Q2 2019, an estimated $17K.
Little House Capital first reported a position in Labcorp in Q1 2019 and held it in 1 quarter.
Little House Capital's Labcorp position peaked at $17K in Q1 2019.
741 funds tracked by Wall St. Rank held Labcorp as of Q2 2019.

Based on Little House Capital's 13F filing for Q2 2019, filed 14 Aug 2019.